Regis Repko reports sale of 4,376 DUK shares
DUK reports Form 144 insider sale and planned sale of vested restricted shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DUK reports Form 144 insider sale and planned sale of vested restricted shares. Regis Repko reported a sale of $556,539.68 for 4,376 common shares on 02/20/2026. The filing also lists 962 common shares tied to restricted stock vesting with a 02/22/2026 date and compensation as the source.
Insights
Routine insider disposition and a small vested award are reported; impact appears immaterial.
The filing documents a reported sale of 4,376 common shares for $556,539.68 on 02/20/2026, and a separate item listing 962 common shares associated with restricted stock vesting on 02/22/2026 as compensation. These figures are explicit in the excerpt.
Timing and cash‑flow treatment are limited to the stated dates; subsequent filings would show whether the vested shares were sold or retained. For governance review, this appears to be routine reporting of insider transactions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 144 for DUK report?
Who reported the insider transaction on the DUK Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.